Research & Education

CAP IASLC AMP Molecular Testing Guideline

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) have developed an evidence-based gu

Novel Agents and biomarker driven therapies for personalized treatment of advanced NSCLC

Implications of the new IASLC staging system and adenocarcinoma classification for systemic treatment of NSCLC - Eric Lim, MB, ChB, MD, MSc, FRCS (C-Th)

Understanding Immunotherapeutic Approaches in Non-Small Cell Lung Cancer

This on-demand webinar offers advice from three experts on immunotherapy in non-small cell lung cancer. Dr. Dmitry Gabrilovich covers basic concepts in immunology; Dr.

Advanced Radiation Technology Webinar Series Session 1: IGRT/SBRT – Presented by Billy Loo, MD and Suresh Senan, MD

The IASLC Advanced Radiation Technology Committee announces a webinar series featuring four 60-minute sessions featuring international experts. In this session, Dr. Hak Choy lets us know about the Advanced Technology Committee's (ART) two-year plan. Dr. Suresh Senan discusses image-guided thoracic radiotherapy in locally advanced lung tumors. Dr. Billy Loo covers image-guided stereotactic ablative radiotherapy (SABR) for early state lung cancer.

Advanced Radiation Technology Committee Session 1: Q&A

IGRT/SBRT Introduction - Q&A session with Dr. Billy Loo and Dr. Suresh Senan. 

Advanced Radiation Technology Committee Session 2: Motion Control

The IASLC Advanced Radiation Technology Committee announces a webinar series featuring four 60-minute sessions featuring international experts. In this session, Dr. Jan Jakob Sonke and Dr.

Advanced Radiation Technology Committee Session 3: Treatment Planning

The IASLC Advanced Radiation Technology Committee announces a webinar series featuring four 60-minute sessions featuring international experts. In this session, Dr.

Advanced Radiation Technology Committee Session 4: SBRT Delivery

The IASLC Advanced Radiation Technology Committee announces a webinar series featuring four 60-minute sessions featuring international experts. In this session, Dr.

Molecular Testing for Non-small Cell Lung Cancer: Introduction and 10 Most Important Questions

At the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology, experts in molecular testing gathered to discuss critical questions in molecular testing for non-small cell lung cancer. In this segment, Dr. David Gandara covers the introduction and the 10 most important questions.

Molecular Testing for Non-small Cell Lung Cancer: How to obtain tissue and which tissue to obtain, and how to coordinate with pathology

At the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology, experts in molecular testing gathered to discuss critical questions in molecular testing for non-small cell lung cancer. In this segment, Dr. Harvey Pass discusses how to obtain tissue, which tissue to obtain and how to coordinate with pathology.

Pages